Home/Pipeline/Green Memory Study

Green Memory Study

Alzheimer's Disease

Not Disclosed (Sponsor-led)Active

Key Facts

Indication
Alzheimer's Disease
Phase
Not Disclosed (Sponsor-led)
Status
Active
Company

About ActivMed Practices and Research

ActivMed is a well-established, private clinical research site organization with a 30-year operational history in the New England region. It provides clinical trial services to a diverse sponsor base, from large pharmaceutical companies to local biotechs, specializing in neurology, psychiatry, dermatology, and primary care conditions. The company has adapted to decentralized trial trends by offering virtual trial capabilities and community-focused telehealth services, such as free memory screenings, to support patient recruitment and engagement. Its business model is entirely service-based, generating revenue from clinical trial contracts.

View full company profile

Other Alzheimer's Disease Drugs

DrugCompanyPhase
NUZ-001Neurizon TherapeuticsPreclinical
ALZN002Alzamend NeuroPreclinical
P021Phanes BiotechPreclinical
PB43DPhanes BiotechPreclinical
UB-311VaxxinityPhase 2
LecanemabBioArcticLaunched
BAN2401BioArcticPreclinical
Undisclosed Programsjohnson-and-johnson-innovative-medicinePipeline
MK-6240 (florquinitau)Lantheus Medical ImagingRegulatory Filing
NAV-4694 (flutafuranol)Lantheus Medical ImagingPhase 3
LNTH-2620/PI-2620Lantheus Medical ImagingPhase 3
itMSCsStemedica Cell TechnologiesClinical Development